Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>The FDA outlined its stance on the exploding field of regenerative medicine in a new paper,&nbsp;trying to strike a balance in stem cell research oversight to temper risk without blunting reward.</p>

FDA Outlines Position on Stem Cell Research